Companies / United Kingdom
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
Teva, Taro Target UK
November 2006 | Company Finance AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
Israeli drugmakers Teva and Taro are to expand activities in the UK. Teva - the world's largest generics firm - has signed a deal with Schering-Plough to co-promote products for Inflammatory Bowel Disease (IBD) for the UK market. Meanwhile, Taro has secured two approvals for generic formulations of branded products made by two UK